Magnolia Bio

Private

Cambridge-based biotech engineering AI-designed macrocyclic peptide therapies for cardiovascular disease.

Founders Priya Sharma

CEO Priya Sharma

Company

Founded

2022

Headquarters

Cambridge, United States

Financials

Total Funding

$143M

Sectors

Artificial Intelligence Biotech

magnoliabio.com

Funding History

3 rounds

Series B Jul 31, 2026

$85M

Flagship Pioneering (Lead) ARCH Venture Partners Third Rock Ventures

Series A Sep 15, 2024

$45M

Third Rock Ventures (Lead) ARCH Venture Partners Flagship Pioneering

Seed Feb 15, 2023

$13M

Third Rock Ventures (Lead) ARCH Venture Partners

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.